Evidence map›Paper›PMID 36812599›Full record

ReviewPLOS digital health2022

Global healthcare fairness: We should be sharing more, not less, data.

Kenneth P Seastedt, Patrick Schwab, Zach O'Brien, Edith Wakida, Karen Herrera, Portia Grace F Marcelo, Louis Agha-Mir-Salim, Xavier Borrat Frigola, Emily Boardman Ndulue, Alvin Marcelo and 1 more

Abstract readReview
In one paragraph

Review in PLOS digital health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kenneth P SeastedtBeth Israel Deaconess Medical Center, Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-6345-8217
Patrick SchwabGlaxoSmithKline, Artificial Intelligence & Machine Learning, Zug, Switzerland.
Zach O'BrienAustralian and New Zealand Intensive Care Research Centre (ANZIC-RC), Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Edith WakidaMbarara University of Science and Technology, Mbarara, Uganda.
Karen HerreraQuality and Patient Safety, Hospital Militar, Managua, Nicaragua.ORCID https://orcid.org/0000-0001-8860-2193
Portia Grace F MarceloDepartment of Family & Community Medicine, University of the Philippines, Manila, Philippines.ORCID https://orcid.org/0000-0001-8640-0985
Louis Agha-Mir-SalimInstitute of Medical Informatics, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health), Berlin, Germany.ORCID https://orcid.org/0000-0002-2733-5084
Xavier Borrat FrigolaLaboratory for Computational Physiology, Harvard-MIT Division of Health Sciences & Technology, Cambridge, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-9348-9284
Emily Boardman NdulueDepartment of Journalism, Northeastern University, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0001-9859-1627
Alvin MarceloDepartment of Surgery, University of the Philippines, Manila, Philippines.ORCID https://orcid.org/0000-0001-6250-9169
Leo Anthony CeliLaboratory for Computational Physiology, Harvard-MIT Division of Health Sciences & Technology, Cambridge, Massachusetts, United States of America.ORCID https://orcid.org/0000-0001-6712-6626

Funding

Critical Care Informatics: Ethical considerations around the use and sharing of health-related dataR01EB017205 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CELI, LEO ANTHONY G, MARK, ROGER GREENWOOD · 2014 to 2021
$3.8M
NIBIB NIH HHS R01 EB017205
6 · The paper itself

Abstract

The availability of large, deidentified health datasets has enabled significant innovation in using machine learning (ML) to better understand patients and their diseases. However, questions remain regarding the true privacy of this data, patient control over their data, and how we regulate data sharing in a way that that does not encumber progress or further potentiate biases for underrepresented populations. After reviewing the literature on potential reidentifications of patients in publicly available datasets, we argue that the cost-measured in terms of access to future medical innovations and clinical software-of slowing ML progress is too great to limit sharing data through large publicly available databases for concerns of imperfect data anonymization. This cost is especially great for developing countries where the barriers preventing inclusion in such databases will continue to rise, further excluding these populations and increasing existing biases that favor high-income countries. Preventing artificial intelligence's progress towards precision medicine and sliding back to clinical practice dogma may pose a larger threat than concerns of potential patient reidentification within publicly available datasets. While the risk to patient privacy should be minimized, we believe this risk will never be zero, and society has to determine an acceptable risk threshold below which data sharing can occur-for the benefit of a global medical knowledge system.

Identifiers

PMID36812599
PMCPMC9931202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.